BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients

Cancer Letters

Volumn 273, Issue 2, 2009, Pages 221-224

  Ang, Pei Woon ^a,b   Li, Wei Qi ^a,b   Soong, Richie ^b   Iacopetta, Barry ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

APC; BRAF; CIMP; Colorectal cancer

Indexed keywords

ADULT; ARTICLE; BRAF GENE; CANCER GRADING; CANCER STAGING; COLORECTAL CANCER; CPG ISLAND; FEMALE; GENE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; PHENOTYPE; PRIORITY JOURNAL;

ADULT; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MIDDLE AGED; PHENOTYPE; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 57349105084     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.08.001     Document Type: Article

References (27)

1. Hawkins N., Norrie M., Cheong K., Mokany E., Ku S., Meagher A., O'Connor T., and Ward R. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 122 (2002) 1376-1387
2. van Rijnsoever M., Grieu F., Elsaleh H., Joseph D., and Iacopetta B. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 51 (2002) 797-802
3. Samowitz W., Sweeney C., Herrick J., Albertsen H., Levin T., Murtaugh M., Wolff R., and Slattery M. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129 (2005) 837-845
4. Teodoridis J., Hardie C., and Brown R. CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett. 268 (2008) 177-186
5. Jass J. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50 (2007) 113-130
6. Weisenberger D., Siegmund K., Campan M., Young J., Long T., Faasse M., Kang G., Widschwendter M., Weener D., Buchanan D., Koh H., Simms L., Barker M., Leggett B., Levine J., Kim M., French A., Thibodeau S., Jass J., Haile R., and Laird P. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38 (2006) 787-793
7. Ogino S., Cantor M., Kawasaki T., Brahmandam M., Kirkner G., Weisenberger D., Campan M., Laird P., Loda M., and Fuchs C. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 55 (2006) 1000-1006
8. Ogino S., Kawasaki T., Kirkner G., Kraft P., Loda M., and Fuchs C. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J. Mol. Diagn. 9 (2007) 305-314
9. Kambara T., Simms L., Whitehall V., Spring K., Wynter C., Walsh M., Barker M., Arnold S., McGivern A., Matsubara N., Tanaka N., Higuchi T., Young J., Jass J., and Leggett B. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53 (2004) 1137-1144
10. Iacopetta B., Grieu F., Li W., Ruszkiewicz A., Caruso M., Moore J., Watanabe G., and Kawakami K. APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer. Int. J. Cancer 119 (2006) 2272-2278
11. Samowitz W., Sweeney C., Herrick J., Albertsen H., Levin T., Murtaugh M., Wolff R., and Slattery M. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 65 (2005) 6063-6069
12. Lee S., Cho N., Choi M., Yoo E., Kim J., and Kang G. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Pathol. Int. 58 (2008) 104-113
13. Ferracin M., Gafà R., Miotto E., Veronese A., Pultrone C., Sabbioni S., Lanza G., and Negrini M. The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile. J. Pathol. 214 (2008) 594-602
14. Watson N., Grieu F., Morris M., Harvey J., Stewart C., Schofield L., Goldblatt J., and Iacopetta B. Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer. J. Mol. Diagn. 9 (2007) 472-478
15. Li W., Kawakami K., Ruszkiewicz A., Bennett G., Moore J., and Iacopetta B. BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol. Cancer 5 (2006) 2
16. Soong R., and Iacopetta B. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors. Mod. Pathol. 10 (1997) 252-258
17. Ang P.W., Toh H.B., Iacopetta B., and Soong R. Cycle threshold value: an improved quality control for bisulfite treated DNA in methylation analysis. Clin. Chem. Lab. Med. 46 (2008) 1117-1121
18. Morris M., Platell C., and Iacopetta B. A population-based study of age-related variation in clinicopathological features, molecular markers and outcome from colorectal cancer. Anticancer Res. 27 (2007) 2833-2838
19. Oliveira C., Velho S., Moutinho C., Ferreira A., Preto A., Domingo E., Capelinha A., Duval A., Hamelin R., Machado J., Schwartz S.J., Carneiro F., and Seruca R. KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene 26 (2007) 158-163
20. Nagasaka T., Sasamoto H., Notohara K., Cullings H., Takeda M., Kimura K., Kambara T., MacPhee D., Young J., Leggett B., Jass J., Tanaka N., and Matsubara N. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J. Clin. Oncol. 22 (2004) 4584-4594
21. Tanaka H., Deng G., Matsuzaki K., Kakar S., Kim G., Miura S., Sleisenger M., and Kim Y. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer. Int. J. Cancer 118 (2006) 2765-2771
22. Iacopetta B., Grieu F., Phillips M., Ruszkiewicz A., Moore J., Minamoto T., and Kawakami K. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa. Cancer Sci. 98 (2007) 1454-1460
23. Yang S., Farraye F., Mack C., Posnik O., and O'Brien M. BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum. Am. J. Surg. Pathol. 28 (2004) 1452-1459
24. Spring K., Zhao Z., Karamatic R., Walsh M., Whitehall V., Pike T., Simms L., Young J., James M., Montgomery G., Appleyard M., Hewett D., Togashi K., Jass J., and Leggett B. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131 (2006) 1400-1407
25. Kawakami K., Ruszkiewicz A., Bennett G., Moore J., Grieu F., Watanabe G., and Iacopetta B. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br. J. Cancer 94 (2006) 593-598
26. Samowitz W., Slattery M., Sweeney C., Herrick J., Wolff R., and Albertsen H. APC mutations and other genetic and epigenetic changes in colon cancer. Mol. Cancer Res. 5 (2007) 165-170
27. Crott J., Liu Z., Keyes M., Choi S., Jang H., Moyer M., and Mason J. Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signalling and folate uptake in human colonic epithelial cell lines. J. Nutr. Biochem. 19 (2008) 328-335